Paper32965124
Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways.
An L and 7 others. Nano Lett, 2020. Cited by 151 papers, by iCite.
Cite this record
ConductScience Library. Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways. Papers, record 32965124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32965124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Experimental | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Animals | |
| Inflammation | |
| NF-kappa B | |
| Pentacyclic Triterpenes |
Source PubMed
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953758 | Triptolide and Celastrol for Rheumatoid Arthritis: Mechanism-Guided Nanoarchitectonics for Delivery Strategies to Enhance Efficacy and Reduce Toxicity. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42953758 | PubMed |
| 42946860 | Deciphering the mechanistic landscape of notch signaling in autoimmune pathogenesis. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/42946860 | PubMed |
| 42884078 | Celastrol in Rheumatoid Arthritis: Immunomodulatory Mechanisms, Multicellular Convergence, and Translational Challenges. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42884078 | PubMed |
| 42763682 | Injectable Hyaluronic Acid-Functionalized Nanocomposite Hydrogel for Targeted Rheumatoid Arthritis Therapy via Concurrent ROS Attenuation and Macrophage Repolarization. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42763682 | PubMed |
| 42746078 | Folate-modified liposomal celastrol for rheumatoid arthritis: therapeutic efficacy and modulation of ROS/NF-κB/COX-2-related inflammatory signaling. | Front Immunol | 2026 | https://conductscience.org/library/papers/42746078 | PubMed |
| 42509726 | Overcoming the Druggability Hurdles of Celastrol: A Critical Review of Advanced Drug Delivery Strategies. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509726 | PubMed |
| 42437940 | Macrophage Notch1 drives hepatocyte ferroptosis via the exosomal miR-142a-3p/TIPE2 axis to promote MASH progression. | Cell Biosci | 2026 | https://conductscience.org/library/papers/42437940 | PubMed |
| 42357311 | Orally Administered Self-Microemulsifying Celastrol Alleviates Rheumatoid Arthritis by Modulating the Expression of TNF-α. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357311 | PubMed |
| 42325403 | Nanomedicine Strategies for Rheumatoid Arthritis: Precision Delivery and Immune Microenvironment Modulation. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42325403 | PubMed |
| 41910697 | Targeting NF-κB and JAK/STAT pathways in rheumatoid arthritis: emerging nanocarrier-based drug delivery approaches. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41910697 | PubMed |
| 41883322 | Influence of heat-reinforcing Needling on the PPAR-γ/NF-κB signaling pathway in the synovial membrane of rats with rheumatoid arthritis. | Histol Histopathol | 2026 | https://conductscience.org/library/papers/41883322 | PubMed |
| 41767600 | Microfluidic Nanocomposite Lubricating Microgels Localized Deliver Celastrol for Remodeling the Immune Microenvironment to Enhance Osteoarthritis Treatment. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/41767600 | PubMed |
| 41737466 | Dynamic microenvironment-regulated hydrogels releasing celastrol lead to urethral scarless repair. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41737466 | PubMed |
| 41408107 | Celastrol suppresses bone destruction in rheumatoid arthritis by inhibiting ALOX5 expression in macrophages via the NF-κB pathway. | Sci Rep | 2025 | https://conductscience.org/library/papers/41408107 | PubMed |
| 41332942 | Prodrug-loaded micelles targeting articular cavity reactive oxygen species for rheumatoid arthritis treatment. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41332942 | PubMed |
| 40936516 | From Physicochemical Constraints to Clinical Prospects of Celastrol: Challenges and Nano Delivery Strategies. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40936516 | PubMed |
| 40874697 | Celastrol Activates SIRT1/PGC-1α/Nrf2 Axis to Inhibit Oxidative Damage for Subconjunctival Fibrosis Alleviation. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40874697 | PubMed |
| 40794372 | Therapeutic efficacy of celastrol in experimental polyarthritis: insights from a meta-analysis of in vivo studies. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/40794372 | PubMed |
| 40406100 | A comprehensive review of natural products in rheumatoid arthritis: therapeutic potential and mechanisms. | Front Immunol | 2025 | https://conductscience.org/library/papers/40406100 | PubMed |
| 40391077 | Celastrol suppresses neovascularization in rat aortic vascular endothelial cells stimulated by inflammatory tenocytes via modulating the NLRP3 pathway. | Open Med (Wars) | 2025 | https://conductscience.org/library/papers/40391077 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NOTCH1 | 4851 | PubTator's text mining | https://conductscience.org/library/genes/4851 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32965124
GET https://conductscience.org/api/papers/v1/32965124/cited_by?page=2